Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Comparison of the Effects of Indobufen and Aspirin in Older Patients with Coronary Artery Disease After Coronary Drug-Eluting Stent Implantation: A Prospective Randomized Single-Center Study.
Wu Y, Gao Z, Jin Q, Zheng J, Xu H, Tu X.
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241309633. doi: 10.1177/10760296241309633.
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial.
Kirtane AJ, Généreux P, Lewis B, Shlofmitz RA, Dohad S, Choudary J, Dahle T, Pineda AM, Shunk K, Maehara A, Popma A, Redfors B, Ali ZA, Krucoff M, Armstrong E, Kandzari DE, O'Neill W, Kraemer C, Stiefel KM, Jones DE, Chambers J, Stone GW; ECLIPSE Investigators.
Lancet. 2025 Apr 12;405(10486):1240-1251. doi: 10.1016/S0140-6736(25)00450-7. Epub 2025 Mar 30.
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCT.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, Kakuta T, Yamazaki S, Shibata Y, Scott D, Vrolix M, Menon M, Möllmann H, Werner N, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Verheye S; BIOADAPTOR-RCT Collaborators.
JACC Cardiovasc Interv. 2025 Apr 28;18(8):988-997. doi: 10.1016/j.jcin.2025.01.426. Epub 2025 Feb 26.
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.
Erlinge D, Andersson J, Fröbert O, Törnerud M, Hamid M, Kellerth T, Grimfjärd P, Winnberg O, Jurga J, Wagner H, Zwackman S, Adielsson M, Alström P, Masoe E, Ulvenstam A, Millgård J, Böhm F, Held C, Renlund H, Oldgren J, Smits PC, Elek C, Abizaid A, James S.
Lancet. 2024 Nov 2;404(10464):1750-1759. doi: 10.1016/S0140-6736(24)02227-X. Epub 2024 Oct 28.
Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation.
Hong SJ, Kim H, Ahn CM, Kim JS, Kim BK, Ko YG, Hong BK, Choi D, Jang Y, Hong MK.
Yonsei Med J. 2019 Sep;60(9):824-831. doi: 10.3349/ymj.2019.60.9.824.
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R.
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?
Levent F, Senoz O, Emren SV, Emren ZY, Gediz RB.
Herz. 2022 Feb;47(1):73-78. doi: 10.1007/s00059-021-05036-z. Epub 2021 Apr 24.
Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease.
Higami H, Shiomi H, Niki S, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Shioi T, Ono K, Kimura T.
Cardiovasc Interv Ther. 2015 Jul;30(3):189-97. doi: 10.1007/s12928-014-0297-x. Epub 2014 Sep 7.
Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis.
Karrowni W, Makki N, Dhaliwal AS, Vyas A, Blevins A, Dughman S, Girotra S, Cram P, Horwitz PA.
J Invasive Cardiol. 2014 Jun;26(6):229-33.
